Kedrion S.p.A

In News

Kedrion Biopharma closes 2024 with a growth of +10% and unveils its new identity - Yahoo Finance

Yahoo Finance - Apr 14, 2025

Case Report: Respiratory lesions successfully treated with intravenous plasminogen, human-tvmh, replacement therapy in four patients with plasminogen deficiency type 1 - Frontiers

Frontiers - Sep 19, 2024

FDA Approves 10% IVIG Formulation For Adults With Primary Humoral Immunodeficiency - Pharmacy Times

Pharmacy Times - Sep 29, 2025

It’s official, Permira strikes control of leading plasma derivatives maker Kedrion and British competitor BPL. Together with ADIA. The Marcucci family and FSI fund to reinvest in the deal. Cdp Equity takes a call option – BeBeez International - BeBeez International

BeBeez International - Jan 21, 2022

U.S. Intravenous Immunoglobulin Market Size to Hit USD 14.42 Billion by 2033 - BioSpace

BioSpace - Feb 26, 2025

Romanian competition body fines five European pharma companies on collusion - Romania Insider

Romania Insider - Feb 16, 2022

KEDPLASMA Announces Nationwide Facility Remodeling Project - PR Newswire

PR Newswire - Nov 01, 2023

US Immunoglobulin Market Size, Share | Industry Report [2034] - Fortune Business Insights

Fortune Business Insights - Sep 28, 2026

KEDPLASMA USA Expanding with Two More Plasma Collection Centers; Ongoing Growth Continues to Benefit Rare Disease Patients - BioSpace

BioSpace - Jul 24, 2018

Coagulation Factors Market Size, Share, Analysis | Report [2034] - Fortune Business Insights

Fortune Business Insights - May 19, 2025

FSI to buy a 35% stake in Sterling as capital increase for supporting the pharma company growth - BeBeez International

BeBeez International - Aug 01, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment